United Cannabis Corp.

United Cannabis Corp.

United Cannabis remains dedicated to advancing the use of cannabinoids as a medicine across the globe.
Biotechnology
1d 5d 1m 6m 1y Max

United Cannabis Corp. News

18 Jun

David J. Scott Joins United Cannabis Corp Board of Directors

DENVER, June 18, 2019 -- United Cannabis Corporation (OTCBB: CNAB) (the “Company” or “United Cannabis”) today announced the appointment of David J. Scott to the Company’s Board.

25 Apr

United Cannabis Corporation Surpasses Significant Hurdle in Pending Patent Litigation

United Cannabis Corporation (CNAB) (the “Company” or “United Cannabis”) surpassed a significant hurdle in its pending patent infringement case against Pure Hemp Collective when United States District Judge...

02 Apr

United Cannabis Corporation Establishes Partnership With John Easterling, Founder Of Amazon Herb Company

United Cannabis Corporation (CNAB) (the “Company” or “United Cannabis”) today announced that it has entered into a Partnership with John Easterling, environmentalist and founder of the multi-million dollar...

12 Feb

United Cannabis Corporation Establishes Joint Venture for Industrial Hemp Processing Facility in South Caro

DENVER, CO / ACCESSWIRE / February 12, 2019 / United Cannabis Corporation (CNAB) (the ''Company'' or ''United Cannabis'') today announced that it has entered into a Joint Venture with Blue Water Green...

31 Jan

Uptick Newswire Hosts United Cannabis Corporation on the Stock Day Podcast to Discuss Their Industrial Hemp

Uptick Newswire Stock Day Podcast welcomed United Cannabis Corporation (CNAB), a biotechnology company dedicated to the development of phyto-therapeutic based products supported by patented technologies...

15 Jan

United Cannabis Corporation Opens Colorado Hemp Testing Facility

DENVER, CO / ACCESSWIRE / January 15, 2019 / United Cannabis Corporation (CNAB) (the "Company" or "United Cannabis") today announced that it has launched an industrial hemp testing facility in Golden,...

13 Dec

United Cannabis Corporation Provides Operations Update

DENVER, CO / ACCESSWIRE / December 13, 2018 / United Cannabis Corporation (CNAB) (the "Company" or "United Cannabis") today provided an update on its operations. The Company experienced a 60-day delay...

09 Oct

United Cannabis Corporation Gives Guidance on Third Quarter Results

Revenues for the third quarter 2018 are $2 million, and approximately $4.2 for the year to date. The current harvest season has alleviated the seasonal shortage and, thus, Management believes the Company...

25 Sep

United Cannabis Corporation Receives Conditional Approval From Jamaica's Cannabis Licensing Authority

DENVER, CO / ACCESSWIRE / September 25, 2018 / United Cannabis Corporation (CNAB) (the "Company" or "United Cannabis") today announced that its Joint Venture (the "Joint Venture" or "UCANN/CRD"), which...

01 Aug

United Cannabis Corporation Begins Clinical Trials On Its Prana P1 THC Activated Capsules For Chronic Pain

DENVER, CO / ACCESSWIRE / August 1, 2018 / United Cannabis Corporation (CNAB) (the "Company" or "United Cannabis") today announced that it has initiated clinical trials on its Prana Bio Nutrient Medicinals...

Load more

About United Cannabis Corp.

The Company’s Chief Executive and Chief Technologies Officers have been involved with medical cannabis since it was permissible in California in 1999, turning their focus to Colorado during the infancy stage of legalizing medical cannabis in 2009. With the benefit of more than 30 years’ combined experience, United Cannabis has accumulated an extensive knowledgebase across the spectrum of the cannabis industry, including engineered facilities, security, regulatory compliance, genetics, cultivation, good manufacturing practices (GMP), proprietary extraction methods, branding, retail operations (SOP), marketing and wholesale distribution.

Once cannabis was approved for medical use in Colorado, the team began working closely with patients who were finding relief from a variety of chronic conditions and disease, in order to optimize their results. The results were extremely encouraging, as indicated by patient testimonials. With success, the patient base grew, providing more data, and in turn, evidence for the effectiveness of particular therapies. These cannabinoid sequencing protocols serve as the basis for United Cannabis’ Prana Bio Nutrient Medicinals and A.C.T. Now Programs.

Accredited with observational data from more than 15,000 patients to date, the Company’s success with Prana Bio Nutrients and A.C.T. Now Program garnered significant attention within the medical community, including Brent Reynolds Ph.D, (listed below) who went on to join the United Cannabis Medical Advisory Board

Participation in events

Jobs

Position
City
Type
Salary
Posted
CITY:
Longmont Colorado, United States
TYPE:
Full-Time
SALARY:
$15 - $18 an hour
POSTED:
13 Mar 2019
$ 0.00
Symbol:
CNAB